H. Abbenhuis, M. Pfeffer, J. Sutter, A. De-cian, J. Fischer et al., Carbon-carbon and carbon-nitrogen bond formation mediated by ruthenium (II) complexes: synthesis of (1H)-isoquinolinium derivatives, Organometallics, vol.12, p.4464, 1993.

R. Agami, G. Blandino, M. Oren, and Y. Shaul, Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis, Nature (Lond), vol.399, pp.809-813, 1999.

R. E. Aird, J. Cummings, A. A. Ritchie, M. Muir, R. E. Morris et al., In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer, Br J Cancer, vol.86, pp.1652-1657, 2002.

A. Cs and P. J. Dyson, Ruthenium in medicine: current clinical uses and future prospects, Platinum Metals Rev, vol.45, p.62, 2001.

M. A. Bennett and A. K. Smith, Arene ruthenium (II) complexes formed by dehydrogenation of cyclohexadienes with ruthenium (III) chlorides, J Chem Soc Dalton Trans, vol.2, pp.233-241, 1974.

H. J. Brady, G. , and G. , Bax. The pro-apoptotic Bcl-2 family member, Bax, Int J Biochem Cell Biol, vol.30, pp.647-650, 1998.

M. J. Clarke, Ruthenium metallopharmaceuticals, Coord Chem Rev, vol.236, p.209, 2003.

M. J. Clarke, F. Zhu, and F. Dr, Non-platinum chemotherapeutic metallopharmaceuticals, Chem Rev, vol.99, pp.2511-2534, 1999.

G. Damia, L. Filiberti, F. Vikhanskaya, L. Carrassa, Y. Taya et al., Cisplatinum and taxol induce different patterns of p53 phosphorylation, Neoplasia, vol.3, pp.10-16, 2001.

A. Eastman, The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes, Pharmacol Ther, vol.34, pp.155-166, 1987.

W. S. El-deiry, The role of p53 in chemosensitivity and radiosensitivity, vol.22, pp.7486-7495, 2003.

S. Fan, W. S. El-deiry, I. Bae, J. Freeman, D. Jondle et al., gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents, Cancer Res, vol.54, pp.5824-5830, 1994.

S. Fernandez, M. Pfeffer, V. Ritleng, and C. Sirlin, An effective route to cycloruthenated N-ligands under mild conditions, Organometallics, vol.18, p.2390, 1999.

H. N. Fraval and J. J. Roberts, Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells, Cancer Res, vol.39, pp.1793-1797, 1979.

S. Fulda, H. Sieverts, C. Friesen, I. Herr, and K. M. Debatin, The CD95 (APO-1/ Fas) system mediates drug-induced apoptosis in neuroblastoma cells, Cancer Res, vol.57, pp.3823-3829, 1997.

C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives, A subset of tumorderived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain, Mol Cell Biol, vol.21, pp.1874-1887, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-02360323

J. G. Gong, A. Costanzo, H. Q. Yang, G. Melino, W. G. Kaelin et al., The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatininduced DNA damage, Nature (Lond), vol.399, pp.806-809, 1999.

S. Gonzalez, C. Prives, C. , and C. , regulation by Chk1 in response to DNA damage, Mol Cell Biol, vol.23, pp.8161-8171, 2003.

V. M. Gonzalez, M. A. Fuertes, C. Alonso, and J. M. Perez, Is cisplatin-induced cell death always produced by apoptosis?, Mol Pharmacol, vol.59, pp.657-663, 2001.

Z. Guo and P. J. Sadler, Metals in medicine, Angew Chem Int Ed, vol.38, pp.1512-1531, 1999.

M. O. Hengartner, The biochemistry of apoptosis, Nature (Lond), vol.407, pp.770-776, 2000.

K. Katano, R. Safaei, G. Samimi, A. Holzer, M. Rochdi et al., The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells, Mol Pharmacol, vol.64, pp.466-473, 2003.

M. Komatsu, T. Sumizawa, M. Mutoh, Z. S. Chen, K. Terada et al., Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance, Cancer Res, vol.60, pp.1312-1316, 2000.

M. C. Marin, C. A. Jost, L. A. Brooks, M. S. Irwin, J. O'nions et al., A common polymorphism acts as an intragenic modifier of mutant p53 behaviour, Nat Genet, vol.25, pp.47-54, 2000.

R. E. Morris, R. E. Aird, M. Pdel, S. Chen, H. Cummings et al., Inhibition of cancer cell growth by ruthenium(II) arene complexes, J Med Chem, vol.44, pp.3616-3621, 2001.

I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, J Immunol Methods, vol.139, pp.271-279, 1991.

T. Okada, I. M. El-mehasseb, M. Kodaka, T. Tomohiro, K. Okamoto et al., Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance, J Med Chem, vol.44, pp.4661-4667, 2001.

R. F. Ozols, Ovarian cancer, part II: treatment, Curr Probl Cancer, vol.16, pp.61-126, 1992.

C. D. Pozniak, F. Barnabe-heider, V. V. Rymar, A. F. Lee, A. F. Sadikot et al., is required for survival and maintenance of CNS neurons, J Neurosci, vol.22, pp.9800-9809, 2002.

C. Prives and P. A. Hall, The p53 pathway, J Pathol, vol.187, pp.112-126, 1999.

E. G. Rodrigues, L. S. Silva, D. M. Fausto, M. S. Hayashi, S. Dreher et al., Cyclopalladated compounds as chemotherapeutic agents: antitumor activity against a murine melanoma cell line, Int J Cancer, vol.107, pp.498-504, 2003.

S. Y. Shieh, J. Ahn, K. Tamai, Y. Taya, and C. Prives, The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites, Genes Dev, vol.14, pp.289-300, 2000.

T. J. Silhavy, M. L. Berman, and E. Lw, Experiments with Gene Fusion, 1984.

P. L. Simonian, D. A. Grillot, R. Merino, and G. Nunez, Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL, J Biol Chem, vol.271, pp.22764-22772, 1996.

E. White and C. Prives, DNA damage enables p73, Nature (Lond), vol.399, pp.734-735, 1999.

E. Wong and C. M. Giandomenico, Current status of platinum-based antitumor drugs, Chem Rev, vol.99, pp.2451-2466, 1999.

Y. Xiong, G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi et al., is a universal inhibitor of cyclin kinases, Nature (Lond), vol.366, pp.701-704, 1993.

Z. M. Yuan, H. Shioya, T. Ishiko, X. Sun, J. Gu et al., is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage, Nature (Lond), vol.399, pp.814-817, 1999.

H. Zhao and H. Piwnica-worms, ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1, Mol Cell Biol, vol.21, pp.4129-4139, 2001.